EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.11.1.24 | Adenocarcinoma |
23065574 |
ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 1.11.1.24 | Adenocarcinoma |
23186333 |
Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 1.11.1.24 | Adenocarcinoma |
25426613 |
Peroxiredoxin 1 Promotes Pancreatic Cancer Cell Invasion by Modulating p38 MAPK Activity. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
4
0 |
| 1.11.1.24 | Adenocarcinoma |
26261544 |
Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
2 |
| 1.11.1.24 | Adenocarcinoma |
26722077 |
Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 1.11.1.24 | Adenocarcinoma |
30214590 |
Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cells. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
| 1.11.1.24 | Adenocarcinoma |
31197039 |
Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades. |
ongoing research
unassigned |
3
0 |
| 1.11.1.24 | Adenocarcinoma |
31280208 |
Peroxiredoxin V Inhibits Emodin-induced Gastric Cancer Cell Apoptosis via the ROS/Bcl2 Pathway. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
1
4
1 |
| 1.11.1.24 | Adenocarcinoma |
31436131 |
Elucidation of the AGR2 Interactome in Esophageal Adenocarcinoma Cells Identifies a Redox-Sensitive Chaperone Hub for the Quality Control of MUC-5AC. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 1.11.1.24 | Adenocarcinoma |
32908916 |
PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer In Vitro and In Vivo. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
